Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1976 Mar;57(3):700–705. doi: 10.1172/JCI108327

Bone pyrophosphate in uremia and its association with extraosseous calcification.

A C Alfrey, C C Solomons
PMCID: PMC436704  PMID: 175092

Abstract

The mean bone pyrophosphate was 0.360 +/- 0.15 mg/g in 8 controls and 1.22 +/- 1.39 mg/g bone in 27 uremic patients (P less than 0.0025). 13 of the 27 uremic patients had bone pyrophosphate levels greater than 2 SD above control values. The ash content of uremic bones with increased pyrophosphate levels (group II) was 56 +/- 9% as compared to 64 +/- 2% in control bones (P less than 0.01) and 60 +/- 7% in uremic bones having normal pyrophosphate levels (P less than 0.1) (group I). The magnesium content of bones in group II was 338 +/- 47 as compared to 211 +/- 13 (P less than 0.0005) in the controls and 294 +/- 73 mmol/kg ash (P less than 0.05) in group I. In group II, but not group I, there was a significant inverse correlation between duration of dialysis and percent bone ash (r = -0.59) (P less than 0.05). A definite relationship existed between elevated bone pyrophosphate levels and soft tissue calcification. In group II the mean pulmonary calcium content was 530 +/- 459 as compared to 32 +/- 26 mmol/kg/ash in group I (P less than 0.0025). All patients with a bone pyrophosphate level greater than 1.4 mg/g bone had extensive pulmonary calcification. It is concluded that the excess bone pyrophosphate present in some uremic patients is either deposited in the apatite crystal in the transphosphorylated form or else as the magnesium salt since the pyrophosphate is resistant to pyrophosphatase and surface adsorption of pyrophosphate is not altered by the increased bone pyrophosphate levels. The excess bone pyrophosphate could disturb bone calcification mechanisms in uremic patients. The association between increased bone pyrophosphate and soft tissue calcification suggests that the disordered pyrophosphate metabolism may be important in the pathogenesis of extraosseous calcification.

Full text

PDF
700

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alfrey A. C., Miller N. L. Bone magnesium pools in uremia. J Clin Invest. 1973 Dec;52(12):3019–3027. doi: 10.1172/JCI107500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bisaz S., Russell R. G., Fleisch H. Isolation of inorganic pyrophosphate from bovine and human teeth. Arch Oral Biol. 1968 Jun;13(6):683–696. doi: 10.1016/0003-9969(68)90146-5. [DOI] [PubMed] [Google Scholar]
  3. Burton F. G., Neuman M. W., Neuman W. F. On the possible role of crystals in the origins of life. I. The adsorption of nucleosides, nucleotides and pyrophosphate by apatite crystals. Curr Mod Biol. 1969 Oct;3(1):20–26. doi: 10.1016/0303-2647(69)90005-7. [DOI] [PubMed] [Google Scholar]
  4. Cathala G., Brunel C. L'activité pyrophosphatasique de la phosphatase alcaline du cerveau. Biochim Biophys Acta. 1973 Jul 5;315(1):73–82. doi: 10.1016/0005-2744(73)90131-9. [DOI] [PubMed] [Google Scholar]
  5. David D. S., Sakai S., Granda J., Cheigh J. S., Riggio R. R., Stenzel K. H., Rubin A. L. Role of pyrophosphate in renal osteodystrophy. Trans Am Soc Artif Intern Organs. 1973;19:440–445. doi: 10.1097/00002480-197301900-00076. [DOI] [PubMed] [Google Scholar]
  6. FLEISCH H., BISAZ S. Mechanism of calcification: inhibitory role of pyrophosphate. Nature. 1962 Sep 1;195:911–911. doi: 10.1038/195911a0. [DOI] [PubMed] [Google Scholar]
  7. Jung A., Bisaz S., Fleisch H. The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals. Calcif Tissue Res. 1973 Mar 30;11(4):269–280. doi: 10.1007/BF02547227. [DOI] [PubMed] [Google Scholar]
  8. KRANE S. M., GLIMCHER M. J. Transphosphorylation from nucleoside Di- and triphosphates by apatite crystals. J Biol Chem. 1962 Sep;237:2991–2998. [PubMed] [Google Scholar]
  9. PERKINS H. R., WALKER P. G. The occurrence of pyrophosphate in bone. J Bone Joint Surg Br. 1958 May;40-B(2):333–339. doi: 10.1302/0301-620X.40B2.333. [DOI] [PubMed] [Google Scholar]
  10. Russell J. E., Avioli L. V. Effect of experimental chronic renal insufficiency on bone mineral and collagen maturation. J Clin Invest. 1972 Dec;51(12):3072–3079. doi: 10.1172/JCI107134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Russell R. G., Bisaz S., Fleisch H. Pyrophosphate and diphosphonates in calcium metabolism and their possible role in renal failure. Arch Intern Med. 1969 Nov;124(5):571–577. [PubMed] [Google Scholar]
  12. Taves D. R., Reedy R. C. A structural basis for the transphosphorylation of nucleotides with hydroxyapatite. Calcif Tissue Res. 1969;3(3):284–292. doi: 10.1007/BF02058670. [DOI] [PubMed] [Google Scholar]
  13. Termine J. D., Posner A. S. Amorphous/crystalline interrelationships in bone mineral. Calcif Tissue Res. 1967;1(1):8–23. doi: 10.1007/BF02008070. [DOI] [PubMed] [Google Scholar]
  14. YENDT E. R., CONNOR T. B., HOWARD J. E. In vitro calcification of rachitic rat cartilage in normal and pathological human sera with some observations on the pathogenesis of renal rickets. Bull Johns Hopkins Hosp. 1955 Jan;96(1):1–19. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES